On Wednesday, April 16, 2025, the third GammaProbe device produced by the knowledge-based company Parto Negar Persia was officially delivered and put into operation at Khatam Al-Anbia Specialty Hospital.
The GammaProbe is a cutting-edge medical device widely used in cancer surgery, particularly for the detection and localization of sentinel lymph nodes. It significantly enhances surgical accuracy and plays a vital role in improving clinical outcomes in oncological procedures.
Parto Negar Persia, as a pioneer in the development and localization of nuclear medicine technologies, has successfully engineered and produced GammaPobe systems in accordance with international standards, drawing on domestic expertise and innovation.
The launch of this device at Khatam Al-Anbia Hospital represents another valuable step toward advancing diagnostic and treatment services for cancer patients, and further demonstrates the growing contribution of Iran’s knowledge-based sector to the country’s healthcare system.
